Viewing Study NCT00468403


Ignite Creation Date: 2025-12-24 @ 7:18 PM
Ignite Modification Date: 2026-02-17 @ 6:49 PM
Study NCT ID: NCT00468403
Status: COMPLETED
Last Update Posted: 2016-04-07
First Post: 2007-05-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: LEA29Y (Belatacept) Emory Edmonton Protocol
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module